why isn t my glp 1 working How Do You Know When Semaglutide GLP-1 Is Working? GLP-1 | Summary

The therapeutic potential of oral semaglutide once daily is being explored in two clinical trials, in populations with and without co-existing vascular disease, studying people at risk of developing Alzheimers disease (NCT04777396 and NCT04777409)

This test does not predict exact GLP-1 response and should not replace medical evaluation

The integration of these insights into clinical practice is expected to improve long-term outcomes and patient satisfaction in diabetes and obesity management

GLP-1 (Glucagon-like peptide-1) is a 30- or 31-amino-acid-long peptide hormone deriving from the tissue-specific posttranslational processing of the proglucagon peptide

The FDA has issued warnings against using compounded or unapproved generic semaglutide versions , as their safety, purity, and dosing consistency cannot be guaranteed

WHAT KAISER REQUIRES FIRST Step Therapy Requirements Even in regions where Kaiser covers Zepbound, you must typically "fail" multiple other treatments first: Kaiser Northwest Example (Most Documented) To qualify for Zepbound coverage in Kaiser Northwest, you must demonstrate: [3] Kaiser Zepbound Coverage Criteria BMI 30 (obesity) OR BMI 27 with a comorbidity (hypertension, diabetes, high cholesterol) Age 18+ Following a structured diet and exercise program (documented, not just attested) Failed at least 2 prior weight loss medications : Phentermine Diethylpropion Qsymia (phentermine/topiramate) Contrave (naltrexone/bupropion) Tried semaglutide (Wegovy or Ozempic) for minimum 6 months and either: It was ineffective (didn't achieve target weight loss) Cannot tolerate due to allergy, serious side effects, or contraindication Continuation Requirements (To Keep Coverage) Initial approval typically for 12 months Must document at least 5% weight loss after starting tirzepatide to continue coverage Bariatric medicine chart review required before switching from semaglutide to Zepbound Kaiser's Internal "Medical Weight Management" Program Kaiser often requires patients to enroll in their internal weight management program before approving GLP-1s